Harvard Bioscience, Inc. (HBIO) News
Filter HBIO News Items
HBIO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HBIO News Highlights
- For HBIO, its 30 day story count is now at 2.
- Over the past 17 days, the trend for HBIO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest HBIO News From Around the Web
Below are the latest news stories about Harvard Bioscience Inc that investors may wish to consider to help them evaluate HBIO as an investment opportunity.
At US$8.25, Is Harvard Bioscience, Inc. (NASDAQ:HBIO) Worth Looking At Closely?While Harvard Bioscience, Inc. ( NASDAQ:HBIO ) might not be the most widely known stock at the moment, it led the... |
Harvard Bioscience, Inc. (HBIO) CEO James Green on Q2 2021 Results - Earnings Call TranscriptHarvard Bioscience, Inc. (HBIO) Q2 2021 Earnings Conference Call August 05, 2021, 08:00 AM ET Company Participants David Sirois - Director, Corporate Accounting & SEC Reporting James Green - Chairman, President and CEO Michael Rossi - CFO Conference Call Participants Paul Knight - KeyBanc Timothy Chiang - Northland Capital Lisa... |
Harvard Bioscience (HBIO) Tops Q2 Earnings and Revenue EstimatesHarvard Bioscience (HBIO) delivered earnings and revenue surprises of 20.00% and 6.56%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock? |
Harvard Bioscience Announces Second Quarter 2021 Financial ResultsStrong double digit revenue growth, solid margin performance despite global supply chain disruptions Revenue up 25% year-over-year as sales momentum continuesCellular and Molecular (CMT) product revenue up 22%Pre-clinical product revenue up 20%Operating margins impacted by higher global supply chain costs HOLLISTON, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and six months ended June 30, 2021. J |
Harvard Bioscience (HBIO) Reports Next Week: What to Know Ahead of the ReleaseHarvard Bioscience (HBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
What Type Of Shareholders Make Up Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Share Registry?The big shareholder groups in Harvard Bioscience, Inc. ( NASDAQ:HBIO ) have power over the company. Generally speaking... |
Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ETHOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID # 6293853. The conference call wi |
10 Best Stocks Under $10 to Buy Right NowIn this article, we will be looking at the 10 best stocks under $10 to buy right now. If you want to skip our detailed analysis on these companies, you can go directly to the 5 Best Stocks Under $10 to Buy Right Now. Investing in cheap stocks can lead to financial success given that […] |
Are You Looking for a Top Momentum Pick? Why Harvard Bioscience (HBIO) is a Great ChoiceDoes Harvard Bioscience (HBIO) have what it takes to be a top stock pick for momentum investors? Let's find out. |
Harvard Bioscience (HBIO) Is a Great Choice for "Trend" Investors, Here's WhyHarvard Bioscience (HBIO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. |